Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PCORI Should Consider Treatment Variations, Financial Consequences In Research Prioritization – Wilensky

Executive Summary

Project HOPE’s Gail Wilensky proposed two key parameters for prioritizing research during a recent workshop hosted by the Patient-Centered Outcomes Research Institute: variations in treatment across the nation and financial consequences of treatment. Other speakers also offered advice on prioritization, while PCORI staff revealed challenges faced in the prioritization process.

You may also be interested in...

PCORI Initiates A Targeted Approach To Research At November Meeting

In a departure from asking researchers to propose specific research topics within broadly defined areas, the board of the Patient-Centered Outcomes Research Institute approved a plan to fund research in three targeted areas – treatment of uterine fibroids, management of asthma in African-Americans and prevention of falls in the elderly – and up to two additional areas.

Patients Could Play A Role In PCORI Research Application Reviews – Exec Director Selby

The notion of patient engagement in the research process could extend so far as to include reviewing applications submitted to the Patient-Centered Outcomes Research Institute, Executive Director Joseph Selby says.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts